Evidence map›Paper›PMID 31611644›Full record

ArticleNature microbiology2019

Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by IL-1Ra.

Daisy X Ji, Livia H Yamashiro, Katherine J Chen, Naofumi Mukaida, Igor Kramnik, K Heran Darwin, Russell E Vance

Erratum issuedAbstract read
In one paragraph

Article in Nature microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 122 papers.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

122 citing papers in PubMed, 189 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. mBio · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Polymorphisms in IRF3 exon 1 influence the immune response to Brucella infection in small ruminants.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Article
  15. Article
  16. Review
  17. Article
  18. Molecular signaling in coinfection: howFrontiers in immunology · 2026
    Review
  19. Review
  20. Article

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Daisy X JiDivision of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
Livia H YamashiroDivision of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
Katherine J ChenDivision of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
Naofumi MukaidaDivision of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.ORCID http://orcid.org/0000-0002-4193-1851
Igor KramnikThe National Emerging Infectious Diseases Laboratory, Department of Medicine (Pulmonary Center), and Department of Microbiology, Boston University School of Medicine, Boston, MA, USA.
K Heran DarwinDepartment of Microbiology, New York University School of Medicine, New York, NY, USA.
Russell E VanceDivision of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA. rvance@berkeley.edu.ORCID http://orcid.org/0000-0002-6686-3912
University of California, Berkeley · USBoston University · USHoward Hughes Medical Institute · USKanazawa University · JPNew York University · US

Funding

The role of Listeria cyclic-di-AMP during infection and immunityP01AI063302 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI PORTNOY, DANIEL A · 2004 to 2025
$45.5M
Necrosis in pulmonary TB granulomas: dynamics, mechanisms, therapiesR01HL126066 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KRAMNIK, IGOR, NIEDERWEIS, MICHAEL · 2016 to 2025
$5.6M
Functional and Structural Dissection of Inflammasome ActivationR37AI075039 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI RUSSELL E VANCE · 2018 to 2026
$3.8M
Specificity and in vivo function of the Naip/Nlrc4 inflammasomesR01AI075039 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI VANCE, RUSSELL E · 2008 to 2017
$3.6M
Aberrant immune activation in the tuberculosis granuloma: a pivotal role in necrosisR01HL133190 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BISHAI, WILLIAM RAMSES, KRAMNIK, IGOR · 2016 to 2019
$3.0M
NHLBI NIH HHS R01 HL126066NHLBI NIH HHS R01 HL133190NIAID NIH HHS P01 AI063302NIAID NIH HHS R01 AI075039NIAID NIH HHS R37 AI075039
6 · The paper itself

Abstract

The bacterium Mycobacterium tuberculosis (Mtb) causes tuberculosis and is responsible for more human mortality than any other single pathogen

Indexed as

Genetic Predisposition to DiseaseAllelesAnimalsCytokinesDisease Models, AnimalFemaleInterferon Type IInterleukin 1 Receptor Antagonist ProteinLungMacrophagesMaleMiceMice, CongenicReceptors, SomatostatinSpecific Pathogen-Free OrganismsTuberculosisCytokinesIl1rn protein, mouseInterferon Type IInterleukin 1 Receptor Antagonist ProteinReceptors, Somatostatinsomatostatin receptor 1, mouse

Identifiers

PMID31611644
PMCPMC6879852
OpenAlexW2980237913

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.